We recently discovered decreased activity of nuclear factor-erythroid 2-related factor 2 (NFE2L2; referred to here as NRF2) in the epidermis of lesional and, to a lesser extent, of non-lesional skin of AD patients using a discovery proteomics approach (Koch et al., 2023). The gene discussed is NFE2L2; the disease is Alzheimer disease.